BIO ANNOUNCES 2001-2002 BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE

  • Contact: DAN ERAMIAN (202) 962-9200
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (July 17, 2001) The Biotechnology Industry Organization (BIO) today released a list of members of the 2001-2002 Board of Directors and the Executive Committee.

"We are extremely pleased to have industry representatives of such high caliber serve on our board," said Carl B. Feldbaum, BIO president. "Their expertise and leadership will prove invaluable to our membership as our pioneering technology continues to break new ground in finding therapies for diseases such as Parkinson's, Alzheimer's, various cancers and diabetes, as well as new solutions to improve agriculture," said Feldbaum.

Members elected to the Executive Committee include Chairman David E. Robinson, Vice Chairman for Food and Agriculture Hendrik Verfaillie, Vice Chairman for Health Care Richard F. Pops, Secretary Thomas G. Wiggans, Treasurer Duane J. Roth, and Ex-Officio former Chairman Mark Skaletsky.

Board of Directors

align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
align=left>
  David W. Anstice

Merck & Co., Inc.

West Point, Pennsylvania




* Walter H. Moos, Ph.D.

Mitokor

San Diego, California
  Frank Baldino, Jr., Ph.D.

Cephalon, Inc.

West Chester, Pennsylvania



* James Mullen

Biogen, Inc.

Cambridge, Massachusetts
  Terence Barnett

Novartis Corporation

New York, New York



  H. Stewart Parker

Targeted Genetics Corporation

Seattle, Washington
  Ernesto Bertarelli

Serono International SA

Geneva, Switzerland




  Richard F. Pops

Alkermes, Inc.

Cambridge, Massachusetts
  Simon G. Best

Ardana Bioscience Ltd.

Edinburgh, United Kingdom




* Edwin C. Quattlebaum, Ph.D.

MetaMorphix, Inc.

Baltimore, Maryland
  Wolf-Dieter Busse, Ph.D.

Bayer Corporation

Berkeley, California






  Hollings Renton

Onyx Pharmaceuticals, Inc.

Richmond, California
* Nancy T. Chang, Ph.D.

Tanox, Inc.

Houston, Texas




  Norbert G. Riedel, Ph.D.

Baxter International, Inc.

Roundlake, Illinois
  Robert Chess

Inhale Therapeutic Systems, Inc.

San Carlos, California




  David E. Robinson

Ligand Pharmaceuticals, Inc.

San Diego, California
  Ralph E. Christoffersen, Ph.D.

Ribozyme Pharmaceuticals, Inc.

Boulder, Colorado



  Duane J. Roth

Alliance Pharmaceutical Corp.

San Diego, California
* Charles A. Fischer

Dow AgroSciences

Indianapolis, Indiana




  James E. Rurka

Microcide Pharmaceuticals, Inc.

Mountain View, California
  Edward V. Fritzky

Immunex Corporation

Seattle, Washington Research






  John A. Ryals

Paradigm Genetics

Triangle Park, North Carolina
  L. Patrick Gage, Ph.D.

Wyeth-Ayerst Research

Collegeville, Pennsylvania






  Una S. Ryan, Ph.D.

AVANT Immunotherapeutics, Inc.

Needham, Massachusetts
* Donal J. Geaney

Elan Corporation, plc.

Dublin, Ireland




* Edward T. Shonsey

Syngenta Seeds, Inc.

Golden Valley, Minnesota
* William A. Haseltine, Ph.D.

Human Genome Sciences, Inc.

Rockville, Maryland




  Mark Skaletsky

The Althexis Co., Inc.

Waltham, Massachusetts
  Wayne T. Hockmeyer, Ph.D.

MedImmune, Inc.

Gaithersburg, Maryland


  Frederick W. Telling, Ph.D.

Pfizer, Inc.

New York, New York
  David P. Holveck

Centocor, Inc.

Malvern, Pennsylvania




  Henri A. Termeer

Genzyme Corporation

Cambridge, Massachuetts
  Vaughn M. Kailian

COR Therapeutics, Inc.

South San Francisco, California




  Hendrik Verfaillie

Monsanto Company

St. Louis, Missouri
  Louis G. Lange, M.D., Ph.D.

CV Therapeutics, Inc.

Palo Alto, California




  John P. Walker

Axys Pharmaceuticals, Inc.

Atherton, California
  Edward Lanphier

Sangamo BioSciences, Inc.

Richmond, California




  Roy A. Whitfield

Incyte Genomics, Inc.

Palo Alto, California
  Benjamin F. McGraw, Ph.D.

Valentis, Inc.

Burlingame, California




  Thomas G. Wiggans

Connetics Corporation

Palo Alto, California
  Alex McPherson, M.D., Ph.D.

Biomira, Inc.

Edmonton, Alberta, Canada




   

* Indicates new board member

BIO represents more than 1000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.